CXCL13 and neoplasm: Flow cytometry showed that the ratios of tumor-infiltrating CD4+ and CD8+ T lymphocytes were significantly elevated in the CXCL13-overexpressing tumor, compared with parental 4T1 and 4T1-pCDH (Fig. 5A, B).